Mohammad-Ali Jenabian1, Mohamed El-Far2, Kishanda Vyboh1, Ido Kema3, Cecilia T Costiniuk4, Rejean Thomas5, Jean-Guy Baril6, Roger LeBlanc7, Cynthia Kanagaratham8, Danuta Radzioch8, Ossama Allam9, Ali Ahmad9, Bertrand Lebouché10, Cécile Tremblay11, Petronela Ancuta11, Jean-Pierre Routy12. 1. Chronic Viral Illnesses Service Research Institute. 2. CHUM Research Centre. 3. Department of Laboratory Medicine, University Medical Center, University of Groningen, The Netherlands. 4. Chronic Viral Illnesses Service Division of Infectious Diseases. 5. Clinique Médicale l'Actuel. 6. Clinique Médicale Quartier Latin. 7. Chronic Viral Illnesses Service Clinique Médicale OPUS. 8. Research Institute. 9. Department of Microbiology and Immunology CHU Ste-Justine Research Center, University of Montreal, Quebec, Canada. 10. Chronic Viral Illnesses Service. 11. CHUM Research Centre Department of Microbiology and Immunology. 12. Chronic Viral Illnesses Service Research Institute Division of Hematology, McGill University Health Centre.
Abstract
BACKGROUND: Tryptophan (Trp) catabolism into kynurenine (Kyn) contributes to immune dysfunction in chronic human immunodeficiency virus (HIV) infection. To better define the relationship between Trp catabolism, inflammation, gut mucosal dysfunction, and the role of early antiretroviral therapy (ART), we prospectively assessed patients early after they acquired HIV. METHODS: Forty patients in the early phase of infection were longitudinally followed for 12 months after receiving a diagnosis of HIV infection; 24 were untreated, and 16 were receiving ART. Kyn/Trp ratio, regulatory T-cells (Tregs) frequency, T-cell activation, dendritic cell counts, and plasma levels of gut mucosal dysfunction markers intestinal-type fatty acid-binding protein, soluble suppression of tumorigenicity 2, and lipopolysaccharide were assessed. RESULTS: Compared with healthy subjects, patients in the early phase of infection presented with elevated Kyn/Trp ratios, which further increased in untreated patients but normalized in ART recipients. Accordingly, in untreated subjects, the elevated Treg frequency observed at baseline continued to increase over time. The highest CD8(+) T-cell activation was observed during the early phase of infection and decreased in untreated patients, whereas activation normalized in ART recipients. The Kyn/Trp ratio was positively associated with CD8(+) T-cell activation and levels of inflammatory cytokines (interleukin 6, interferon γ-inducible protein 10, interleukin 18, and tumor necrosis factor α) and negatively associated with dendritic cell frequencies at baseline and in untreated patients. However, ART did not normalize plasma levels of gut mucosal dysfunction markers. CONCLUSIONS: Early initiation of ART normalized enhanced Trp catabolism and immune activation but did not improve plasma levels of gut mucosal dysfunction markers.
BACKGROUND:Tryptophan (Trp) catabolism into kynurenine (Kyn) contributes to immune dysfunction in chronic human immunodeficiency virus (HIV) infection. To better define the relationship between Trp catabolism, inflammation, gut mucosal dysfunction, and the role of early antiretroviral therapy (ART), we prospectively assessed patients early after they acquired HIV. METHODS: Forty patients in the early phase of infection were longitudinally followed for 12 months after receiving a diagnosis of HIV infection; 24 were untreated, and 16 were receiving ART. Kyn/Trp ratio, regulatory T-cells (Tregs) frequency, T-cell activation, dendritic cell counts, and plasma levels of gut mucosal dysfunction markers intestinal-type fatty acid-binding protein, soluble suppression of tumorigenicity 2, and lipopolysaccharide were assessed. RESULTS: Compared with healthy subjects, patients in the early phase of infection presented with elevated Kyn/Trp ratios, which further increased in untreated patients but normalized in ART recipients. Accordingly, in untreated subjects, the elevated Treg frequency observed at baseline continued to increase over time. The highest CD8(+) T-cell activation was observed during the early phase of infection and decreased in untreated patients, whereas activation normalized in ART recipients. The Kyn/Trp ratio was positively associated with CD8(+) T-cell activation and levels of inflammatory cytokines (interleukin 6, interferon γ-inducible protein 10, interleukin 18, and tumor necrosis factor α) and negatively associated with dendritic cell frequencies at baseline and in untreated patients. However, ART did not normalize plasma levels of gut mucosal dysfunction markers. CONCLUSIONS: Early initiation of ART normalized enhanced Trp catabolism and immune activation but did not improve plasma levels of gut mucosal dysfunction markers.
Authors: Thomas R Ziegler; Suzanne E Judd; Joshua H Ruff; Grace A McComsey; Allison Ross Eckard Journal: AIDS Res Hum Retroviruses Date: 2017-02-27 Impact factor: 2.205
Authors: Wei Cao; Vikram Mehraj; Benoit Trottier; Jean-Guy Baril; Roger Leblanc; Bertrand Lebouche; Joseph Cox; Cecile Tremblay; Wei Lu; Joel Singer; Taisheng Li; Jean-Pierre Routy; S Vézina; L Charest; M Milne; E Huchet; S Lavoie; J Friedman; M Duchastel; F Villielm; P Côté; M Potter; B Lessard; M A Charron; S Dufresne; M E Turgeon; D Rouleau; L Labrecque; C Fortin; A de Pokomandy; V Hal-Gagné; M Munoz; B Deligne; V Martel-Laferrière; N Gilmore; M Fletcher; J Szabo Journal: Clin Infect Dis Date: 2015-09-08 Impact factor: 9.079
Authors: Ivan Vujkovic-Cvijin; Louise A Swainson; Simon N Chu; Alexandra M Ortiz; Clark A Santee; Annalise Petriello; Richard M Dunham; Douglas W Fadrosh; Din L Lin; Ali A Faruqi; Yong Huang; Cristian Apetrei; Ivona Pandrea; Frederick M Hecht; Christopher D Pilcher; Nichole R Klatt; Jason M Brenchley; Susan V Lynch; Joseph M McCune Journal: Cell Rep Date: 2015-11-12 Impact factor: 9.423